Oct 2026
Vitiligo Biomarker CXCL10 Correlates With Clinical Response to Ruxolitinib Cream in the Phase 2 Randomized TRuE-V Mechanism-of-Action Study.
T. Passeron, M. Lebwohl, C. Lynde et al.
· Journal of Investigative Der... · 0 citations